Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Horowitz

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|June 1, 1985
Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloidK Mullin, P J Houghton, J A Houghton, et al.
Cancer|August 15, 1993
Long-term survival after central nervous system relapse in a patient with osteosarcomaL H Wexler, T F DeLaney, S Saris, et al.
Journal of the National Cancer Institute|October 16, 1991
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcomaM A Smith, R S Ungerleider, M E Horowitz, et al.
Genes, Chromosomes & Cancer|November 1, 1992
Cytogenetic studies in subgroups of rhabdomyosarcomaJ Whang-Peng, T Knutsen, K Theil, et al.
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Journal of Oncology Practice|September 22, 2010
Passport for care: implementing the survivorship care planMarc E Horowitz, Michael Fordis, Susan Krause, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Anesthesia and Analgesia|August 31, 2004
Flow rates and warming efficacy with Hotline and Ranger blood/fluid warmersPeter E Horowitz, Miguel A Delagarza, Jaime J Pulaski, et al.
Chest|July 1, 1988
Presentation of Pneumocystis carinii pneumonia as unilateral hyperlucent lungD C Stokes, J L Shenep, M E Horowitz, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|June 1, 1985
Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloidK Mullin, P J Houghton, J A Houghton, et al.
Cancer|August 15, 1993
Long-term survival after central nervous system relapse in a patient with osteosarcomaL H Wexler, T F DeLaney, S Saris, et al.
Journal of the National Cancer Institute|October 16, 1991
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcomaM A Smith, R S Ungerleider, M E Horowitz, et al.
Genes, Chromosomes & Cancer|November 1, 1992
Cytogenetic studies in subgroups of rhabdomyosarcomaJ Whang-Peng, T Knutsen, K Theil, et al.
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Journal of Oncology Practice|September 22, 2010
Passport for care: implementing the survivorship care planMarc E Horowitz, Michael Fordis, Susan Krause, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Anesthesia and Analgesia|August 31, 2004
Flow rates and warming efficacy with Hotline and Ranger blood/fluid warmersPeter E Horowitz, Miguel A Delagarza, Jaime J Pulaski, et al.
Chest|July 1, 1988
Presentation of Pneumocystis carinii pneumonia as unilateral hyperlucent lungD C Stokes, J L Shenep, M E Horowitz, et al.
Pageof 13